231 Safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide for treatment of people with cystic fibrosis with the 3849 +10 kb C- >T mutation to support Phase 1/2a clinical study
DOI:
10.1016/s1569-1993(23)01161-x
Publication Date:
2023-10-18T06:00:09Z
AUTHORS (7)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....